December 2013 – International Meetings

Drs. Smith, Ravits, and Bowser presented a poster at the International ALS meeting in Milan. The presentation summarized the evidence for a novel theory about the progression of sporadic ALS which is currently thought to spread from cell to cell. Dr. Smith and his colleagues propose the initial spread of the disease may occur via the spinal fluid pathway.

The following week, Dr. Smith spoke at the International Clinical Research Center in Brno, Czech Republic.

September 2013 – Conferences and Presentations

September 27, 2013 – Dr. Smith spoke at the Instituto de Biologica y Medicina Experimental in Buenos Aires, Argentina.

October 3, 2013 – Dr. Smith made a brief presentation at the Annual NEALS Conference in Clearwater, Florida regarding an ongoing Treatment Trial that is testing the effect of Nuedexta on speech and swallowing in patients with ALS. This is funded by the ALS Association with additional support provided by NEALS and the Massachusetts General Hospital from funds donated by a patient.

Nuedexta Developed

Nuedexta®, a drug discovered at CNS and developed by Avanir Pharmaceuticals, Inc., was approved for sale in the European market in June. For more information about this exciting news, visit here.